Scarica l'app Stockscreener
1.88
2.73%
0.05
Dopo l'orario di chiusura:
1.88
Precedente Chiudi:
$1.83
Aprire:
$1.81
Volume 24 ore:
131.54K
Relative Volume:
0.44
Capitalizzazione di mercato:
$80.74M
Reddito:
$88.55M
Utile/perdita netta:
$-53.21M
Rapporto P/E:
-1.453
EPS:
-1.2939
Flusso di cassa netto:
$-29.48M
1 W Prestazione:
+1.62%
1M Prestazione:
-8.74%
6M Prestazione:
+44.62%
1 anno Prestazione:
+17.50%
Intervallo 1D:
$1.81
$1.89
Intervallo di 1 settimana:
$1.745
$1.89
Portata 52W:
$1.13
$2.89
Pulmonx Corp Stock (LUNG) Company Profile
Nome
Pulmonx Corp
Settore
Industria
Telefono
650-364-0400
Indirizzo
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.88 | 80.74M | 88.55M | -53.21M | -29.48M | -1.2939 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | Iniziato | D. Boral Capital | Buy |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-04 | Iniziato | Lake Street | Buy |
| 2024-02-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Iniziato | Craig Hallum | Buy |
| 2023-02-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2021-03-25 | Iniziato | Piper Sandler | Neutral |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-10-26 | Iniziato | BofA Securities | Buy |
| 2020-10-26 | Iniziato | Canaccord Genuity | Buy |
| 2020-10-26 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Iniziato | Stifel | Buy |
| 2020-10-26 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Pulmonx Corp Borsa (LUNG) Ultime notizie
Five9 Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
🔥 $LUNC — THE BURN STORY IS STILL ALIVE - Binance
Pulmonx Corp Officer Radhakrishnan Srikanth Sells 14,245 Shares at $2.26 Each (NASDAQ: LUNG) - Kalkine Media
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com South Africa
Pulmonx CEO French Glendon E. III Disposes of 41,882 Shares at $2.26 Each - Kalkine Media
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com South Africa
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com UK
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com Australia
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com South Africa
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com Nigeria
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com Nigeria
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares - Investing.com
Pulmonx general counsel David Lehman sells $32,393 in stock - investing.com
Pulmonx chief science officer sells $32,192 in stock - Investing.com
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com India
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com Canada
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com UK
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com India
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com UK
Insider at Pulmonx (LUNG) sells shares to cover taxes - Stock Titan
Pulmonx (LUNG) exec sells shares to cover RSU taxes - Stock Titan
Pulmonx (LUNG) general counsel sells shares to cover RSU taxes - Stock Titan
Pulmonx Shares Fall Following Recent Gains - Yahoo Finance
Why is Pulmonx stock sliding today? By Investing.com - Investing.com Australia
Why is Pulmonx stock sliding today? - Investing.com
Pulmonx (LUNG) CEO sells 41,882 shares to cover taxes - Stock Titan
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Pulmonx will take investor meetings in Boston and New York Sept. 9-10 - Stock Titan
Pulmonx to Participate in Upcoming Investor Conferences - Yahoo Finance
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy? - Zacks Investment Research
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year - MarketBeat
Pulmonx Corp (NASDAQ: LUNG) Share Price, LUNG Stock News, LUNG Share Price & Updates - Kalkine
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Morgan Stanley (LUNG) reports 6.9% Pulmonx stake in updated ownership filing - Stock Titan
Pulmonx at Canaccord Genuity growth conference: turnaround gains pace - Investing.com
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript - The Globe and Mail
Pulmonx Corp 2026: Revenue $22.76M, EPS ($0.24) — 10-Q Summary - TradingView
Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Earnings Release: Here's Why Analysts Cut Their Pulmonx Corporation (NASDAQ:LUNG) Price Target To US$3.40 - Sahm
LUNG Looks 82.5% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Pulmonx Target of Unusually Large Options Trading (NASDAQ:LUNG) - MarketBeat
Earnings call transcript: Pulmonx tops Q2 2026 estimates, shares jump 14.4% - Investing.com
Pulmonx Q2 Revenue Falls 5 Percent To $22.8 Million - Quiver Quantitative
Pulmonx Reports Second Quarter 2026 Financial Results - Yahoo Finance
Pulmonx's Aug. 11 Boston fireside chat will be webcast live - Stock Titan
LUNG|Pulmonx Corp|Price:1.225|Chg%:+0.055 - TradingKey
Pulmonx Corp (LUNG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pulmonx Corp expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Pulmonx Reports Q1 2026 Earnings with Strategic Outlook - Intellectia AI
Pulmonx Corp Azioni (LUNG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pulmonx Corp Azioni (LUNG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lehman David Aaron | General Counsel |
Sep 01 '26 |
Sale |
2.26 |
14,334 |
32,395 |
361,827 |
| Rose Geoffrey Beran | Chief Commercial Officer |
Sep 01 '26 |
Sale |
2.26 |
7,879 |
17,807 |
449,832 |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer |
Sep 01 '26 |
Sale |
2.26 |
14,245 |
32,194 |
316,994 |
| French Glendon E. III | President and CEO |
Jun 02 '26 |
Sale |
1.57 |
13,511 |
21,212 |
1,178,162 |
| Lehman David Aaron | GENERAL COUNSEL |
Jun 01 '26 |
Sale |
1.54 |
14,594 |
22,475 |
376,161 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Jun 01 '26 |
Sale |
1.54 |
8,023 |
12,355 |
457,711 |
| French Glendon E. III | President and CEO |
Jun 01 '26 |
Sale |
1.54 |
42,638 |
65,663 |
1,191,673 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer |
Jun 01 '26 |
Sale |
1.54 |
14,497 |
22,325 |
331,239 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Mar 02 '26 |
Sale |
1.43 |
7,732 |
11,057 |
365,734 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer |
Mar 02 '26 |
Sale |
1.43 |
10,483 |
14,991 |
170,736 |
0.49%
8.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):